What you need to know
You must advise which ESC or MSAC meeting you intend to lodge your ADAR for. This ensures our secretariat has enough time to organise an ADAR commentary or ADAR overview paper before the meeting.
If you fail to lodge an ADAR as intended, there is no penalty. Notify your intent again when you are ready.
-
If your application is Pharmaceutical Benefits Advisory Committee (PBAC) codependent, indicate this when you notify your intent to lodge. This ensures our secretariat will liaise with the PBAC secretariat.
This applies to both streamlined and integrated codependent applications.
What you need to do
1. Confirm the deadline
To confirm the notification deadline, go to key dates for applicants and refer to the meeting date you plan to lodge your ADAR for.
2. Confirm the status of any regulatory approvals
Some services and technologies need regulatory approvals. The process for these approvals must have begun before you notify your intent. This ensures we can finalise the outcome of your application as quickly as possible.
If the process has not begun and is not likely to before the notification deadline, consider notifying your intent to lodge for a later meeting date.
3. Consider the availability of evidence or trial outcomes
Confirm any new evidence or clinical trial outcomes you want to include in your ADAR will be available before the lodgement deadline. If this is not likely, consider notifying your intent to lodge for a later meeting date.
4. Notify your intent to lodge
You must use the Health Products Portal to notify your intent. You will receive a confirmation of receipt.
Next steps
The next step is to lodge your ADAR.
Contact
Contact your application manager or our secretariat if you have any questions.
